We are live on !
Find out more
Virtus Investment Advisers Portfolio holdings
AUM
$429M
Turnover
23.4%
1-Year Est. Return
52.51%
This Fund
S&P 500
This Quarter Est. Return
+23.54%
1 Year Est. Return
+52.51%
3 Year Est. Return
+172.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$429M
AUM Growth
+$66.7M
(+18%)
Cap. Flow
+$19.4M
Cap. Flow % of AUM
Cap. Flow %
4.52%
Top 10 Holdings %
Top 10 Hldgs %
7.64%
Holding
517
New
67
Increased
228
Reduced
168
Closed
54
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$3.47M |
| 2 |
Datadog
DDOG
|
+$2.53M |
| 3 |
Marvell Technology
MRVL
|
+$2.28M |
| 4 |
Western Digital
WDC
|
+$2.19M |
| 5 |
NetApp
NTAP
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Day One Biopharmaceuticals
DAWN
|
+$2.17M |
| 2 |
Linde
LIN
|
+$2.08M |
| 3 |
Hershey
HSY
|
+$2.06M |
| 4 |
Live Nation Entertainment
LYV
|
+$1.97M |
| 5 |
Coca-Cola
KO
|
+$1.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.77% |
| 2 | Technology | 15.15% |
| 3 | Financials | 13.21% |
| 4 | Industrials | 12.74% |
| 5 | Consumer Discretionary | 5.44% |
Similar funds
PA
Virtus Investment Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Virtus Investment Advisers held 517 positions worth $429M, up 18% from $363M the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Virtus Investment Advisers deployed $19.4M of net new capital in Q2 2026, opening 67 new positions and adding to 228 existing holdings. Its largest new stake was Devon Energy: 74,863 shares worth $3.09M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 32% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ImmunityBio, an estimated $1.47M trimmed.
- Virtus Investment Advisers's largest Q2 2026 buy was Devon Energy: 74,863 shares worth $3.09M.
- Virtus Investment Advisers added most to Omeros in Q2 2026, an estimated $1.26M increase.
- Virtus Investment Advisers's biggest Q2 2026 reduction was ImmunityBio, cutting an estimated $1.47M.
- Virtus Investment Advisers fully exited Day One Biopharmaceuticals in Q2 2026, selling an estimated $2.17M.
- Virtus Investment Advisers's ten largest holdings make up 7.6% of its $429M portfolio in Q2 2026.
- Virtus Investment Advisers opened 67 new positions and closed 54 in Q2 2026.
- Virtus Investment Advisers's portfolio value rose 18% quarter-over-quarter to $429M.
Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.